Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP 2: switching from ticagrelor to prasugrel in stable coronary artery disease
2011-004064-29Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prasugrel and ticagrelor in coronary arteriosclerosis (3 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: P2Y12 reaction units by VerifyNow P2Y12 assay at 7 days. Started Mar 2012; status: completed.
02
Drugs
prasugrelticagrelor
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-004064-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004064-29.